Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Devdatt Kurdikar | President, CEO & Director | 2.2M | -- | 1969 |
| Mr. Jacob P. Elguicze | Senior VP & CFO | 1.05M | -- | 1973 |
| Mr. Jeffrey Z. Mann | Senior VP, General Counsel, Head of Business Development & Corporate Secretary | 959.45k | -- | 1972 |
| Mr. Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain | 915.67k | -- | 1969 |
| Ms. Colleen Riley | Senior VP & Chief Technology Officer | -- | -- | 1964 |
| Mr. Pravesh Khandelwal | VP & Head of Investor Relations | -- | -- | -- |
| Ms. Ginny Blocki | Senior Vice President of Global Marketing & Product Management | -- | -- | -- |
| Ms. Jean M. Casner | Senior VP & Chief Human Resources Officer | -- | -- | 1958 |
| Mr. Tom Blount | Senior VP & President of North America | -- | -- | 1974 |
| Mr. Slobodan Radumilo | Senior VP & President of International | -- | -- | 1970 |
Embecta Corp.
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees:
- 2,200
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Corporate Governance
Upcoming Events
February 7, 2025 at 1:30 PM UTC - February 11, 2025 at 1:30 PM UTC
Embecta Corp. Earnings Date
Recent Events
December 18, 2024 at 12:00 AM UTC
Dividend Date
August 27, 2024 at 12:00 AM UTC
Ex-Dividend Date
May 28, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)